Selenium is of fundamental importance to human health. It is an essential component of several major metabolic pathways, including thyroid hormone metabolism, antioxidant defence systems, and immune function. The decline in blood selenium concentration in the UK and other European Union countries has therefore several potential public health implications, particularly in relation to the chronic disease prevalence of the Western world such as cancer and cardiovascular disease. Ten years have elapsed since recommended dietary intakes of selenium were introduced on the basis of blood glutathione peroxidase activity. Since then 30 new selenoproteins have been identified, of which 15 have been purified to allow characterisation of their biological function. The long term health implications in relation to declining selenium intakes have not yet been thoroughly examined, yet the implicit importance of selenium to human health is recognised universally. Selenium is incorporated as selenocysteine at the active site of a wide range of selenoproteins. The four glutathione peroxidase enzymes (classical GPx1, gastrointestinal GPx2, plasma GPx3, phospholipid hydroperoxide GPx4)) which represent a major class of functionally important selenoproteins, were the first to be characterised. Thioredoxin reductase (TR) is a recently identified seleno-cysteine containing enzyme which catalyzes the NADPH dependent reduction of thioredoxin and therefore plays a regulatory role in its metabolic activity.
Introduction
In 1818 the Swedish chemist Jons Jacob Berzelius discovered selenium. He named it Selene after the Greek goddess of the moon. One hundred and forty years later, Schwarz and Foltz identified selenium as essential to animal health when they discovered that trace amounts protected against liver necrosis in vitamin E deficient rats 1 . Interest in the role of selenium in human health gathered momentum in the late 1960's, and investigations looked for human diseases similar to those of Se-responsive animal disorders 2 . Although selenium was identified as essential to human nutrition 42 years ago, a universal marker of daily requirement remains elusive. Research has extended our knowledge of the essential functional roles attributed to selenium, which have both short-, and long-term public health implications.
Selenoproteins
Selenium is an essential micronutrient of major metabolic significance. It is incorporated as selenocysteine at the active site of a wide range of proteins. Under physiological conditions the Se in selenocysteine is almost fully ionised and consequently is an extremely efficient biological catalyst 3 . It has been suggested that up to 100 selenoproteins may exist in mammalian systems 4 of which up to 30 have been identified by 75Se labelling in vivo 5 . To date 15 selenoproteins have been purified or cloned allowing further characterisation of their biological function. These include four glutathione peroxidase enzymes (classical GPx1, gastrointestinal GPx2, plasma GPx3, phospholipid hydroperoxide GPx4) which represent a major class of functionally important selenoproteins. The Se peroxidases are genetically, structurally and kinetically different yet have both common and individual functions 3 .
Glutathione peroxidase
Classical glutathione peroxidase (GPx1) was the first selenoprotein, identified, and the strong linear relationship demonstrated between erythrocyte Se concentration and GSHPx activity provided us with the first functional biochemical marker of Se status 6 . GSHPx is present in the cell cytosol where it functions as an antioxidant by directly reducing H 2 O 2 , and phospholipase A2 cleaved lipid hydroperoxides 6 . It may also act as a storage vehicle for Se 7 containing 4 selenocysteine residues in a tetrameric structure.
Gastrointestinal glutathione peroxidase
Gastrointestinal glutathione peroxidase (GPx2) protects mammals from the toxicity of ingested lipid hydroperoxides 8 . In animal studies, Se deficiency decreases the enzyme activity, but any effect on human GPx2 activity has not been reported. Gastrointestinal glutathione peroxidase is the most important selenoprotein antioxidant in the colon. Oxidative stress is a critical event in tumourogenesis. It is therefore likely that the antioxidant function of GPx2 will provide an early defence against colon cancer.
Phospholipid hydroperoxide glutathione peroxidase A membrane associated phospholipid hydroperoxide glutathione peroxidase (GPx4) has been identified which is directly responsible for the reductive destruction of lipid hydroperoxides 9 . The enzyme is a monomer and its activity is preserved in preference to GPx1 when dietary Se supply is low 10 . GPx4 reacts with phospholid hydroperoxides as well as small soluble hydroperoxides 11 , and is also capable of metabolising cholesterol and cholesterol ester hydroperoxides in oxidised low density lipoprotein. Consequently it is well recognised as essential to destruction of fatty acid hydroperoxides, which if not reduced to hydroxy fatty acids, will lead to uncontrolled free radical chain reactions that are deleterious to the integrity of membranes. In animal models, the amount of the protein GPx4 present in tissues does not exactly reflect the activity distribution. This may be a reflection of site specific Se dependent cell function, or differences in the level of factors which activate GPx4. The mechanism for the activation-inactivation of the enzyme is unknown, but the evidence of high activity in membranes of differentiating spermatogenic cells suggests a possible relationship between cell differentiation and peroxide levels 12 .
Extracellular glutathione peroxidase Extracellular GSHPx (GPx3) is another selenoprotein with antioxidant potential, but this may not be its main function in plasma. Hybridization studies show that GPx3 mRNA occurs in the renal proximal tubular epithelial cells 13 , and since the concentrations of GSH are high in the kidney, GPx3 may have a specific antioxidant function in renal tubules or extracellular spaces. However, other thiols such as thioredoxin can act as electron donor and support an antioxidant role for GPx3 in plasma 14 . Thioredoxin is a protein disulphide important to antioxidant defences and the regulation of cell growth.
Thioredoxin reductase
Thioredoxin reductase is a recently identified selenocysteine containing enzyme which catalyzes the NADPH dependent reduction of thioredoxin and therefore plays a regulatory role in its metabolic activity 15 . This discovery extends the role of Se to redox regulation. Since thioredoxin stimulates proliferation of normal and tumour cells, and is present in high concentrations in tumour cells 16 , an enhanced TR activity may play an important role in the prevention of some forms of cancer.
Selenoprotein P Approximately 60% of Se in plasma is incorporated in selenoprotein P which contains 10 Se atoms per molecule as selenocysteine 4 . Extracellular GSHPx, and selenoprotein-P account for over 90% of plasma selenium and both may serve as a transport protein for Se 17 . However, selenoprotein-P is also expressed in many tissues and has been associated with cell membranes 18 which suggests that although it may facilitate whole body Se distribution, this may not be its sole function, and it may serve as an antioxidant.
Iodothyronine deiodinases
A second major class of selenoproteins are the iodothyronine deiodinase enzymes which catalyse the 5 H 5-mono-deiodination of the prohormone thyroxine (T 4 ) to the active thyroid hormone 3,3
H 5-triiodothyronine (T 3 ) and the conversion of inactive reverse T3 to 3-3 H diiodothyronine. Thyroid hormones play a regulatory role in hepatic enzyme expression and neutrophil function. Consequently, in animal Se repletion studies, the lack of a relationship between the effect on drug metabolising enzymes and glutathione metabolism in the liver, neutrophil function, and changes in GSHPx activity prompted investigations into the association between Se and thyroid status 19 . Full activity of the thyroid hormones is dependent on the deiodination of thyroxine to triiodothronine (T 3 ). Most T3 is produced by the peripheral deiodination of T 4 catalysed by the type 1 selenoenzyme iodothyronine 5
H deiodinase (IDI). There are three types of Se dependent iodothyronine deiodinase enzymes which function in specific tissues such as liver and brain, to maintain plasma and organ thyroid hormone homeostasis. Conversion of T4 to T3 can be assessed by monitoring the T 3 /T 4 ratio in blood. There is a progressive reduction of this ratio with ageing which can be reversed with Se supplementation 20 . Thus the total T 3 /total T 4 ratio may serve as a functional marker of Se status in human studies. It may be logical to hypothesise that the regulatory role of thyroid hormones over cellular metabolic rate will be modulated by Se status, the requirement for which will increase in response to increased activity of the cell.
Seleno-phosphate synthetase
Mechanisms for selenocysteine incorporation into functional selenoproteins involve an inorganic precursor, probably seleno-phosphate 4 . The fact that most dietary Se occurs in an organic form as either selenocysteine or selenomethione, suggests that the in vivo conversion to an inorganic precursor is an important regulator of Se bioavailability. This regulatory control may confer protection against excessive incorporation of Se into selenoproteins during protein synthesis, and may be of particular importance in preventing toxicity from excessive intakes.
Sperm capsule selenoprotein GPx4
GPx4 exists as a soluble peroxidase in spermatids but persists in mature spermatozoa as an enzymatically inactive, oxidatively cross-linked, insoluble protein 21 . Spermatozoa contain the highest concentrations of selenium of any mammalian tissue, with requirement increasing at the onset of spermatogenesis. At least 50 percent of the capsule material which supports the helix of mitochondria is GPx4 21 . An insufficient Se supply impairs sperm mitochondrial capsule synthesis which affects sperm motility and may induce sterility. Selenium supplementation studies in infertile men increase seminal fluid Se concentration and improve sperm motility 22 . The potential influence of Se on the increasing male sterility in Europe is an important consideration when assessing Se requirement in men.
Selenoprotien W
In animal studies, Se intake effects tissue concentrations of selenoprotein W which is reported to be necessary for muscle metabolism 23 . Skeletal muscle calcification in sheep and cattle, known as white muscle disease, is prevented by Se supplementation 24 . The importance of selenoprotein W to human skeletal muscle metabolism is not yet fully understood, but the recent cloning of its cDNA will enhance research into human muscle disease such as muscular dystrophies which have been shown to respond to Se supplementation. A myopathy caused by selenium deficiency, described as white muscle disease, has been reported in anorexia nervosa 25 .
Dietary selenium and human requirement
Selenium is present in soil and enters the food chain through plants. We obtain most of our dietary Se from bread, cereal, meat and poultry (Table 1) . Tissue levels of Se are readily influenced by dietary intake which itself is governed by geographical differences in available selenium in soil. In general, soil concentration of available Se is low in Europe. Bioavailability of Se is also low and has decreased further as a consequence of increasing acid rain and use of excessive fertilisation. Generally speaking, human blood Se levels follow the same geographical pattern around the world as those of livestock in the same regions 26 . Although Se deficiency in animals has long been recognised, obvious clinical signs of human Se deficiency are rare. The exception is in areas of North-East China with very low soil Se where an endemic, fatal cardiomyopathy, Keshan disease, was found to respond to Se supplementation. Asymptomatic low Se status is also reported in New Zealand, Finland and areas of the Eastern United States where government mandates have initiated . Values in areas of Greece, West Germany, Sweden, Spain, Denmark, France, Belgium, the Netherlands, and the UK are reported to be lower than the 1.2 mmol/L required for optimal (defined as maximal) GPx1 activity ( Table 2 ). In Finland, increasing dietary selenium intakes using selenium enriched fertilizers, from an average of 25 mg/day to 70 mg/day had the effect of raising serum selenium concentrations from 0.63 mmol/L in the 1970's to 1.42 mmol/L in the 1990's. The health implications of this change have not been reported.
Selenium presents a nutritional conundrum because it is both essential and highly toxic. Measurement of glutathione peroxidase activity has been used as a marker of adequacy of intake because activity of the enzyme is proportional to dietary intake. Comparing dietary intakes from different geographical regions where Se soil concentrations are very different has provided information on the intake required to maximise glutathione peroxidase activity. In the Se depleted region of North east China Se intakes of below 11 mg Se/day are causally linked to the endemic juvenile cardiomyopathy, Keshan disease. In a study of adult men living in this area of China who were supplemented with 30 mg of selenomethionine/day plasma GPx3 activity increased to what was considered maximum activity 29 . Dietary intakes of 41 mg Se/day were subsequently considered sufficient to meet the Se requirement of men with an average body weight of 60 kg. This data was used as the basis on which to make recommendations. The Scientific Committee for Food has proposed that 40 mg Se/day is a sufficient average intake for the European Community 30 . Discussions on Se requirements by FAO, IAEA, and WHO suggest intakes of 40 mg and 30 mg are sufficient to meet normal requirements of adult males and females respectively 31 . Such judgements of requirement are based on Se intakes sufficient to allow expression of two-thirds of erythrocyte GPx1 activity, with lower limits of safe population intakes calculated from basal metabolic rate. These values do not meet the recommendation that selenium intake should approximate 1 mg/kg body weight. Since supra-nutritional levels of Se intake are required to reduce the incidence of animal and human cancers, it is likely that maintaining the activities of known selenoproteins is not the mechanism by which Se acts since it appears to be saturated at normal nutritional intakes. It is 30 years since glutathione peroxidase activity was identified as a functional marker of Se status. Since this time many more selenoproteins have been identified as essential to major metabolic pathways. Consequently, it may be no longer appropriate to rely on glutathione peroxidase activity as an index of adequacy of Se intake. Recommendations are routinely based on intakes which prevent overt symptoms of deficiency. These do not take account of the many more recently identified functional roles of Se. Nor do they address the potential functional effects of chronic marginal intakes of Se which may culminate in chronic disease such as cancer, cardiovascular disease, and increased susceptibility to viral infection. It is of course very difficult to make recommendations, since specific sensitive biochemical markers of functional Se status are not yet available. Moreover, there is growing emphasis on assessing nutrient status with functional rather than static biomarkers.
Selenium and health
The health implications of the decline in Se status in the UK over the past two decades have not been systematically investigated. Dietary intake of Se in the UK is now reported to be only half the UK Reference Nutrient Intake (RNI) of 1 mg Se/kg body weight 32, 33, 34 . Our own research highlights the relatively poor Se status of a UK population 35 with plasma Se levels lower than many other European countries 28 , and levels in erythrocytes half the value previously reported for UK populations 36, 37 . Se supplementation of our volunteers with 50 mg Se/day as sodium selenite or selenomethionine, increased activities of Se dependent peroxidases in plasma and blood cells, indicating that functional Se status may be improved by nutritional means 35 . The different and contrasting effects that Se supplementation had on white blood cell and platelet selenoenzyme activities, and the fact these were seen in only 60±70% of subjects, may be indicative of a difference in metabolic need regulated at the level of Se dependent cell function. Transient spikes in activity of GPx4 an extremely stable enzyme which is preferentially spared in seleniumdepleted animal models, may indicate that it is a marker of increased selenium requirement in humans. Lipid peroxidation is only inhibited by GPx4 if membranes contain sufficient vitamin E, consistent with the proposed synergism between the two antioxidant activities 38 . Subjects who do not respond to Se supplementation may have either sufficient basal levels of expression, an inability to express the protein, or an impaired ability to activate the protein.
Immune function
Although the mechanisms involved have yet to be fully elucidated, it is well established that dietary selenium is important for a healthy immune response 39 . The effects of Se deficiency can include reduced T-cell counts, impaired lymphocyte proliferation and responsiveness 40 . Dietary supplementation of humans with 200 mg of sodium selenite enhances T-lymphocyte immune responses 41 . A progressive decline in plasma Se has been widely reported in adult respiratory distress syndrome (ARDS) and AIDS patients, and approximately parallels T-cell loss or stage of HIV infection. It is particularly noticeable at the terminal stages of disease where Se deficiency is now considered a classical symptom/sign of end stage. There is an extremely high turnover of CD4 T-cells in AIDS, with billions of new cells lost and replaced daily. The constant formation of new cells to replace those lost requires an extremely efficient and effective Se supply to keep up with the high demand in active lymphocytes. Sub-clinical requirement for Se by lymphocytes and granulocytes will clearly not be as great when the immune system is not overly stressed. After selenium supplementation, the range of variation in % change in selenoenzyme activity between individuals may reflect the tocopherol status of the blood cells. Lymphocytes and granulocytes can contain up to 35 times more alpha-tocopherol than red blood cells or platelets, probably reflecting preferential mobilization to cells with different metabolic need. All of these cells are capable of increasing their metabolic activity as a function of their immunosuppressive role. In doing so, membrane sensitive oxidases are generated which oxidise NADH and NADPH thereby increasing O 2 utilization and its subsequent reduction to reactive oxygen species (ROS). Tocopherol and Se supply to these cells is therefore essential to provide control over their functional generation of excessive ROS.
Cancer
There is strong evidence that Se has a protective effect against some forms of cancer. In a recent study involving 1312 patients supplemented with 200 mg Se daily, the incidence of prostate, colon and lung cancers was decreased by 63, 58, and 46% respectively 42 . The mechanism of action of the chemoprotective effects are not known, but may be mediated through the two major Se dependent redox systems in the cell.
The principle cell types that mediate the eradication of toxins and mutated cells in the circulation, are the Tlymphocytes, the synthesis and activation of which may be Se dependent. It appears that the CD4 gene Open Reading Frame may contain the same selenocysteine insertion sequences as mammalian selenoprotein P 43 , thus Se may be important to T-cell protein synthesis and therefore normal cell function. This may be of relevance to the observations of Clark et al. 42 in relation to Se supplementation and cancer aetiology because Tlymphocytes are the principal cell types that eradicate tumour cells. Thioredoxin reductase has recently been identified and purified from human T-cells 43 , and may be important in reducing thioredoxin enhanced tumour cell growth.
Cardiovascular disease
Low blood Se concentrations have been associated with increased cardiovascular disease mortality. This may be a reflection of sub-optimal GPx4 activity in the prevention of LDL oxidation, with subsequent uptake by endothelial cells and macrophages in arterial blood vessels. Heart disease mortality declined by an average 61% in Finland between 1972 and 1992. The decline has been attributed to major lifesyle changes, the most important reported as a 4% fall in energy consumed from fat, with an associated lowering of blood cholesterol concentration. It is highly likely, that the concomitant 3 fold increase in dietary Se intake as a consequence of Se enrichment of fertilizer, since 1985 will also have contributed to lower heart disease mortality reported in 1992.
Asthma
Evidence of an extended role of GPx4 beyond that of an antioxidant comes from the work of Weitzel and Wendel (1993) 44 , who have demonstrated that GPx4 regulates the activity of lymphocyte 5-lipoxygenase, and Steinhilber D. et al. 45 , who show that GPx 4 supresses 5-lypoxygenase activity in lymphocytes and granulocytes. Consequently, GPx 4 may have a regulatory role in the inflammatory response through suppression of lypoxygenase catalysed leukotriene biosynthesis from arachidonic acid. Moreover, it has been hypothesised that vitamin E may have a regulatory influence over leukotriene biosynthesis as a substrate for both n-6 and n-3 unsaturated fatty acid desaturase enzymes 46 . This indication that functional selenium and vitamin E status may influence leucotriene metabolism has important implications in relation to chronic inflammatory disease, particularly asthma which is now the most prevalent chronic inflammatory condition in childhood, and has doubled over the last 20 years in the UK 47 . There is a dramatic rise in the prevalence of asthma in the UK which mirrors the dramatic decline in blood Se concentration. This situation has the potential to exacerbate the imbalance in n6/n3 fatty acid status already recognised as involved in the pathogenesis of the disease. Moreover, Se status is decreased in patients with asthma, as is activity of glutathione peroxidase in platelets and erythrocytes. There is an associated marked oxidant/antioxidant imbalance in the blood of asthmatics, which reflects poor antioxidant status and enhanced inflammatory mediated oxidative stress.
Summary
An adequate dietary supply of Se is essential for selenoenzyme activity. Consequently, the decreased intake of Se and lowered Se status of several European populations is of concern since it may result in sub-optimal selenoenzyme activity which may have deleterious long term health implications.
Many new functional roles for selenium are being identified that still require to be elucidated. This should not however, detract from further investigation into the long term implications of lowered Se status in Europe, the health implications of which have not been systematically investigated.
Selenium is an integral component of at least three major metabolic systems essential for normal cell metabolism 48 . There are no classical overt signs of clinical deficiency in European populations, but there are in populations of North East China where a fatal endemic cardiomyopathy is associated with low dietary Se supply and blood concentration, and is successfully treated by Se supplementation. What is astonishing is that the disease is evident at blood Se levels which are only just lower than in some European subjects. What may be important in terms of the functional role of selenium is the range in blood Se concentrations of our populations.
Blood selenium concentration data does reflect dietary intake but tells us nothing of its functional significance, particularly in relation to its important role in thyroid hormone metabolism, antioxidant defence and redox systems, and the immune response, in particular lymphocyte and neutrophil function. It is also evident from clinical studies that increasing Se intake decreases infection rate, and susceptibility to viral mutation, which might increase the virulence of the pathogen. These biological requirements, and the chemopreventive potential of Se, means there is an urgent need to establish valid biomarkers in terms of functional requirement and adequacy of intake.
Individuals may have differing metabolic needs for selenium regulated at the level of Se dependent cell function, for example in relation to immuno-responsive roles. Of course there will be substantial genetic variation between individuals which is why we must examine nutrient gene interactions in the future. We must also consider other factors such as the regulatory role of alpha-tocopherol, and evaluate the most recent functional roles attributed to selenoproteins as potential markers of requirement. The large intra-individual and inter-individual variations in selenoenzyme activity suggests that it may not on its own be a valid biomarker of functional Se status. Only future research can provide a truly functional measure of adequacy of Se intake.
